PSEUDOMONAS AERUGINOSA SKIN-NASOPHARYNGEAL COLONIZATION IN THE IN-PATIENTS: PREVALENCE, RISK FACTORS AND ANTIBIOTIC RESISTANCE IN TERTIARY HOSPITALS IN SANA'A CITY -YEMEN
Journal Title: Universal Journal of Pharmaceutical Research - Year 2018, Vol 3, Issue 6
Abstract
Pseudomonas aeruginosa is one of most important cause of healthcare-associated infections. This active surveillance cross sectional study was aimed to determine the rate of P. aeruginosa colonization among inpatients at three tertiary hospitals in Sana'a city. In addition, to determine risk factors of colonization and the antibiotic susceptibility of the isolated P. aeruginosa. The study included 327 inpatients. Skin and nasopharyngeal swabs were collected from all participated patients and data were collected by predesigned questionnaire. Standard methods of isolation and identification were used to isolate bacteria in pure culture then identify. Also, antibiotic sensitivity for isolated P. aeruginosa was determined by the disc diffusion method. 42 patients (12.8%) were colonized with P. aeruginosa on skin and nasopharyngeal. The significant risk factors of colonization were male patients (OR=2.5), older age (OR= 2.2), burn ward (OR=37), long stay in hospital (OR=4) and burn as underlying disease (OR=45). The isolated P. aeruginosa were completely resistant (100%), to Aztroneome, Ceftriaxone, and Ciprofloxacine; and the rates of resistant were ranged between 83.3-85.7% for Amikacin, Ampicillin sulbactam Levofloxacin. Also the rates were 71.4% for Netilmicin and 92.9% for chloramphenicol. Moreover, the rates of resistant were low for Gentamicin (35.7%), Imipenem (11.9%), Pipracillin Tazobactam (11.9%), Ticaracillin calvulanic acid (31%) and Colistin sulphat (14.3%). In conclusion, this study has highlighted the role of hospitalization as a significant risk for P. aeruginosa colonization; concerted and coordinated efforts are required both in the hospital and community to tackle this. These data emphasize the need to identify hospitalized patients colonized with P. aeruginosa on admission. Prediction rules or rapid diagnostic testing will help clinicians more appropriately choose empiric antibiotic therapy if subsequent infections occurred.
Authors and Affiliations
Rahma Taher Farea AL-Magrami, Hassan Abdulwahab Al-Shamahy
Keywords
Related Articles
- EP ID EP36500
- DOI https://doi.org/10.22270/ujpr.v3i6.219
- Views 315
- Downloads 0
Editorial Message...
It is great honor and high pleasure to be appointed as member- Editorial Board, then as executive editor, Universal Journal of Pharmaceutical Research (UJPR). My heartiest salutations and warm congratulation to all edito...
Message
The developments of new pharmaceuticals and novel methods of prevention, diagnosis and treatment of diseases would not be possible without significant advancement in pharmaceutical science and technology. The Universa...
PREVALENCE OF HEPATITIS G VIRUS AMONG PATIENTS WITH CHRONIC LIVER DISEASE AND HEALTHY INDIVIDUALS, SANA'A CITY-YEMEN
Hepatitis G virus (HGV) is a newly discovered and enveloped RNA positive-stranded flavivirus-like particle, which has not yet been proven to have major negative effects on liver. Therefore, it is important to estimate th...
Editorial Message..
I would like to deeply congratulate all the Universal Journal of Pharmaceutical Research team for completing 3 successful years since the rise of the journal. It was an honor to join the UJPR team as a member in the Edit...
DEVELOPMENT AND EVALUATION OF IN SITU GELLING GASTRORETENTIVE FORMULATIONS OF MELOXICAM
The aim of this study was to develop a novel gastro retentive oral floating in situ gelling system for controlled release of Meloxicam. Meloxicam is a NSAID that inhibits cyclooxygenase (COX) synthesis and has analgesic...